Health ❯ Vaccines ❯ mRNA Technology

Public Health

Infectious Diseases Pandemic Preparedness Vaccine Development Vaccine Efficacy Vaccine Research Immunization Research Misinformation Funding Cuts Controversies COVID-19

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

Scientists and former health leaders say the reversal undermines rapid vaccine readiness and risks ceding biotech leadership abroad.

U.S. Cancels Moderna’s $600 Million Bird Flu Vaccine Contract